Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

BIFEN SUSPENSION 100 mg/5 ml

Approval Number

SIN08932P

Drug Name

BIFEN SUSPENSION 100 mg/5 ml

Product Name

BIFEN SUSPENSION 100 mg/5 ml

Approval Date

September 20, 1996

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

SUSPENSION

Route of Administration

ORAL

Medical Information

ATC Code

M01AE01

ATC Item Name

ibuprofen

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PT ACTAVIS INDONESIA

Active Ingredients

Ingredient Name

IBUPROFEN

Strength

100 mg/5 ml

Drug MonographIbuprofen

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy